EP 2004205 A4 20100609 - INORGANIC SELENIUM FOR TREATMENT OF BENIGN TUMORS
Title (en)
INORGANIC SELENIUM FOR TREATMENT OF BENIGN TUMORS
Title (de)
ANORGANISCHES SELEN ZUR BEHANDLUNG VON GUTARTIGEN TUMOREN
Title (fr)
SÉLÉNIUM INORGANIQUE UTILISÉ POUR TRAITER DES TUMEURS BÉNINES
Publication
Application
Priority
- AU 2007000393 W 20070329
- US 78732306 P 20060329
Abstract (en)
[origin: WO2007109853A1] The invention relates to the use of selenate or its pharmaceutically acceptable salts, in nutritional or supranutritional amounts, in methods and compositions for inhibiting the growth of benign tumor cells and treating or preventing benign tumors, particularly benign tumors in which the Akt signaling pathway is activated or in which Bcl 2 levels are elevated. Methods of preventing malignant conversion of benign tumors and benign tumor cells to malignant tumors or malignant tumor cells is also described.
IPC 8 full level
A61K 33/04 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 33/04 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2017.12)
Citation (search report)
- [X] SUNDSTROM H ET AL: "Supplementation with selenium vitamin E and their combination in gynaecological cancer during cytotoxic chemotherapy", CARCINOGENESIS, OXFORD UNIVERSITY PRESS, GB LNKD- DOI:10.1093/CARCIN/10.2.273, vol. 10, no. 2, 1 February 1989 (1989-02-01), pages 273 - 278, XP008111298, ISSN: 0143-3334
- See references of WO 2007109853A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2007109853 A1 20071004; AU 2007231549 A1 20071004; CA 2644445 A1 20071004; EP 2004205 A1 20081224; EP 2004205 A4 20100609
DOCDB simple family (application)
AU 2007000393 W 20070329; AU 2007231549 A 20070329; CA 2644445 A 20070329; EP 07718640 A 20070329